Listed

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTCNasdaqCIK 1500198HealthcareFiscal year ends Sep 30

Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

NEUROONE MEDICAL TECHNOLOGIES Corp, Reports and events
FiledFormWhat it isAccession number
2021-06-0820:32 ET8-K5.07 Shareholder vote results0001213900-21-031466
2021-05-2521:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-21-029116
2021-05-1420:16 ET10-QQuarterly reportPeriod 2021-03-310001213900-21-026426
2021-05-0612:37 ETDEF 14AProxy statementPeriod 2021-06-020001213900-21-024789
2021-03-3113:13 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-21-018989
2021-03-0501:30 ETS-1/ARegistration statement, amended0001213900-21-013520
2021-02-2313:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-21-010996
2021-02-1621:49 ET10-QQuarterly reportPeriod 2020-12-310001213900-21-009675
2021-02-1221:25 ET10-K/AAnnual report, amendedPeriod 2020-09-300001213900-21-008993
2021-02-1021:01 ETS-1Registration statement0001213900-21-008033
2021-01-2821:17 ET10-K/AAnnual report, amendedPeriod 2020-09-300001213900-21-004908
2021-01-1513:08 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-21-002402
2021-01-0713:59 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-21-000810
2020-12-0900:36 ET10-KAnnual reportPeriod 2020-09-300001213900-20-041661
2020-10-0612:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-030207
2020-09-0320:17 ET8-K3.02 Unregistered sale of equity0001213900-20-025222
2020-08-2722:59 ETS-1/ARegistration statement, amended0001213900-20-023907
2020-08-1320:27 ET10-QQuarterly reportPeriod 2020-06-300001213900-20-021898
2020-08-1200:12 ETS-1Registration statement0001213900-20-021492
2020-08-0320:17 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-20-019896
2020-07-2812:17 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-018777
2020-07-2212:13 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-018233
2020-07-0218:57 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-20-016538
2020-06-0420:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001213900-20-014109
2020-05-1420:20 ET10-QQuarterly reportPeriod 2020-03-310001213900-20-012278
2020-05-1220:48 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-20-011839
2020-05-0120:43 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-20-010775
2020-05-0113:26 ETDEF 14AProxy statementPeriod 2020-06-020001213900-20-010710
2020-04-3021:27 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-20-010673
2020-04-0621:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-20-008662
2020-02-2413:50 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-20-004573
2020-02-1420:52 ET10-QQuarterly reportPeriod 2019-12-310001213900-20-003930
2020-01-2821:55 ET10-K/AAnnual report, amendedPeriod 2019-09-300001213900-20-002019
2020-01-2421:17 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-20-001745
2019-12-3121:15 ET8-K5.02 Departure or appointment of officers or directors0001213900-19-027296
2019-12-2022:17 ET10-KAnnual reportPeriod 2019-09-300001213900-19-026720
2019-12-1121:24 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-19-025880
2019-12-0421:57 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-19-025318
2019-12-0214:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-19-025070
2019-11-0721:23 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-19-022367
2019-10-2920:56 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-19-021393
2019-10-2922:16 ETSC 13D/AOwnership report, active investor, amended0001104659-19-057011
2019-10-2520:49 ET8-K1.01 Entry into a material agreement0001213900-19-021161
2019-10-1120:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-19-020209
2019-09-2313:42 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-19-018619
2019-08-1420:54 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-19-015854
2019-08-1420:06 ET10-QQuarterly reportPeriod 2019-06-300001213900-19-015795
2019-08-0520:32 ET8-K5.02 Departure or appointment of officers or directors0001213900-19-014618
2019-07-1520:22 ETS-1Registration statement0001213900-19-012721
2019-07-0520:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001213900-19-012136

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.